SRRK - Scholar Rock Holding Corp
Scholar Rock Holding Corp Logo

SRRK - Scholar Rock Holding Corp

https://www.scholarrock.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
As of 2025-09-10 (Snapshot)

Scholar Rock Holding Corporation, a clinical-phase biopharmaceutical company, is focused on the discovery and development of drugs for the treatment of serious diseases in which protein growth factor signaling plays a critical role. The company is headquartered in Cambridge, Massachusetts.

52W High
$46.98
52W Low
$6.76

MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.37
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-2.08
EV/Revenue (<3 favorable)
8.22
P/S (TTM) (<3 favorable)
13.14
P/B (<3 favorable)
12.94
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
4.30%
Institutions (25–75% balanced)
120.39%
Shares Outstanding
96,127,000
Float
80,448,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
-210,163,008
EPS (TTM)
-2.92
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-1.72%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
-1.00
Momentum
Bearish momentum
Value
-0.9557
Previous
-0.9686
Trend
Rising
Signal Cross
No cross

As of
Sep. 12, 2025